Genome News and Research

RSS
Can SARS-CoV-2 host factor protein interactions help identify antiviral drug targets?

Can SARS-CoV-2 host factor protein interactions help identify antiviral drug targets?

Collaborative research could expedite or eliminate the need to manually adjust bioproduction process

Collaborative research could expedite or eliminate the need to manually adjust bioproduction process

Researchers discover how SARS viruses enhance the production of viral proteins in infected cells

Researchers discover how SARS viruses enhance the production of viral proteins in infected cells

Interfering RNA nanoparticles could be a potential COVID-19 therapy

Interfering RNA nanoparticles could be a potential COVID-19 therapy

What do we know about the origin and evolution of SARS-CoV-2?

What do we know about the origin and evolution of SARS-CoV-2?

Researchers explore cost-effective Identification method for novel SARS-CoV-2 variants

Researchers explore cost-effective Identification method for novel SARS-CoV-2 variants

SARS-CoV-2 pandemic underscores importance of understanding evolution of RNA genomes

SARS-CoV-2 pandemic underscores importance of understanding evolution of RNA genomes

Field of mathematics reveals a potential gene that causes acute lymphoblastic leukemia

Field of mathematics reveals a potential gene that causes acute lymphoblastic leukemia

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

Seroprevalence studies monitoring SARS-CoV-2 among vaccinees require more than spike assays

Seroprevalence studies monitoring SARS-CoV-2 among vaccinees require more than spike assays

Children develop strong, long-lasting immunity following SARS-CoV-2 infection

Children develop strong, long-lasting immunity following SARS-CoV-2 infection

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

Systematic review: Exposure to endocrine-disruptors could elevate breast cancer risk

Systematic review: Exposure to endocrine-disruptors could elevate breast cancer risk

Chronic SARS-CoV-2 infections favor viral adaptation, says study

Chronic SARS-CoV-2 infections favor viral adaptation, says study

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

Study reveals why intellectual disability risk for younger sib­lings is low

Study reveals why intellectual disability risk for younger sib­lings is low

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers manufacture the SARS-CoV-2 RBD in pichia

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation